The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Eltrombopag for Thrombocytopenia in Patients with Cirrhosis Associated with Hepatitis C
Abstract
BACKGROUND: Eltrombopag is a new, orally active thrombopoietin-receptor agonist that stimulates thrombopoiesis. We evaluated its ability to increase platelet counts and facilitate treatment for hepatitis C virus (HCV) infection in patients with thrombocytopenia associated with HCV-related cirrhosis. METHODS: Seventy-four patients with HCV-related cirrhosis and platelet counts of 20,000 to less than 70,000 per cubic millimeter were randomly assigned to receive eltrombopag (30, 50, or 75 mg daily) or placebo daily for 4 weeks. The primary end point was a platelet count of 100,000 per cubic millimeter or more at week 4. Peginterferon and ribavirin could then be initiated, with continuation of eltrombopag or placebo for 12 additional weeks. RESULTS: At week 4, platelet counts were increased to 100,000 per cubic millimeter or more in a dose-dependent manner among patients for whom these data were available: in 0 of the 17 patients receiving placebo, in 9 of 12 (75%) receiving 30 mg of eltrombopag, in 15 of 19 (79%) receiving 50 mg of eltrombopag, and in 20 of 21 (95%) receiving 75 mg of eltrombopag (P<0.001). Antiviral therapy was initiated in 49 patients (in 4 of 18 patients receiving placebo, 10 of 14 receiving 30 mg of eltrombopag, 14 of 19 receiving 50 mg of eltrombopag, and 21 of 23 receiving 75 mg of eltrombopag) while the administration of eltrombopag or placebo was continued. Twelve weeks of antiviral therapy, with concurrent receipt of eltrombopag or placebo, were completed by 36%, 53%, and 65% of patients receiving 30 mg, 50 mg, and 75 mg of eltrombopag, respectively, and by 6% of patients in the placebo group. The most common adverse event during the initial 4 weeks was headache; thereafter, the adverse events were those expected with interferon-based therapy. CONCLUSIONS: Eltrombopag therapy increases platelet counts in patients with thrombocytopenia due to HCV-related cirrhosis, thereby permitting the initiation of antiviral therapy. (ClinicalTrials.gov number, NCT00110799.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Multiple Testing Procedure for Clinical Trials
O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics · doi:10.2307/2530245 · Cited by 3,311
McHutchison, J. G., Manns, M., Patel, K., Poynard, T., Lindsay, K. L., Trepo, C., Dienstag, J., Lee, W. M., Mak, C., Garaud, J., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.35950 · Cited by 969
Self-citationTreating viral hepatitis C: efficacy, side effects, and complications
Manns, M. P., Wedemeyer, H., & Cornberg, M. (2006) · Gut · doi:10.1136/gut.2005.076646 · Cited by 659
Hand-Foot Syndrome After Dose-Dense Adjuvant Chemotherapy for Breast Cancer: A Case Series
Bardia, A., Loprinzi, C. L., & Goetz, M. P. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.1143 · Cited by 312
Bashour, F. N., Teran, C. J., & Mullen, K. D. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)01117-5 · Cited by 252
Shiffman, M. L., Ghany, M. G., Morgan, T. R., Wright, E. C., Everson, G. T., Lindsay, K. L., Lok, A. S. F., Bonkovsky, H. L., Di Bisceglie, A. M., Lee, W. M., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.11.011 · Cited by 204
Self-citationAdinolfi, L. E., Giordano, M. G., Andreana, A., Tripodi, M., Utili, R., Cesaro, G., Ragone, E., Mangoni, E. D., & Ruggiero, G. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02824.x · Cited by 200
The Role of Thrombopoietin in the Thrombocytopenia of Patients with Liver Cirrhosis
Rios, R., Sangro, B., Herrero, I., Quiroga, J. A., & Prìeto, J. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41543.x · Cited by 148
Hematological Complications of Alcoholism
Ballard, H. S. (1989) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1989.tb00408.x · Cited by 91
Chronic viral hepatitis C: management update.
Gutfreund, K. S., & Bain, V. G. (2000) · Europe PMC (PubMed Central) · Cited by 34
Cited by
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
Ghany, M. G., Strader, D. B., Thomas, D. L., & Seeff, L. B. (2009) · Hepatology · doi:10.1002/hep.22759 · Cited by 2,973
Neunert, C., Lim, W., Crowther, M., Cohen, A., Solberg, L., & Crowther, M. A. (2011) · Blood · doi:10.1182/blood-2010-08-302984 · Cited by 1,856
EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
(2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.02.023 · Cited by 1,088
EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
(2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.11.003 · Cited by 855
The ITP syndrome: pathogenic and clinical diversity
Cines, D. B., Bussel, J. B., Liebman, H. A., & Luning Prak, E. T. (2009) · Blood · doi:10.1182/blood-2009-01-129155 · Cited by 804
Thrombocytopenia associated with chronic liver disease
Afdhal, N., McHutchison, J., Brown, R., Jacobson, I., Manns, M., Poordad, F., Weksler, B., & Esteban, R. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.03.009 · Cited by 583
Self-citationBussel, J. B., Provan, D., Shamsi, T., Cheng, G., Psaila, B., Kovaleva, L., Salama, A., Jenkins, J. M., Roychowdhury, D., Mayer, B., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60402-5 · Cited by 539
Self-citationPlatelets and Infection – An Emerging Role of Platelets in Viral Infection
Assinger, A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00649 · Cited by 386
Hemostasis and thrombosis in patients with liver disease: The ups and downs
Lisman, T., Caldwell, S. H., Burroughs, A. K., Northup, P. G., Senzolo, M., Stravitz, R. T., Tripodi, A., Trotter, J. F., Valla, D.-C., & Porte, R. J. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.01.042 · Cited by 360
Eltrombopag before Procedures in Patients with Cirrhosis and Thrombocytopenia
Afdhal, N. H., Giannini, E. G., Tayyab, G., Mohsin, A., Lee, J.-W., Andriulli, A., Jeffers, L., McHutchison, J., Chen, P.-J., Han, K.-H., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110709 · Cited by 321
Self-citationPhysiological and pharmacological modulation of BAX
Spitz, A. Z., & Gavathiotis, E. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.11.001 · Cited by 317
120 Crohn's Disease: Factors Associated with Exposure to High Levels of Diagnostic Radiation
Desmond, A. N., O'Regan, K. N., Curran, C., McWilliams, S., Maher, M. M., & Shanahan, F. (2008) · Gastroenterology · doi:10.1016/s0016-5085(08)60102-x · Cited by 307
Management of the critically ill patient with cirrhosis: A multidisciplinary perspective
Nadim, M. K., Durand, F., Kellum, J. A., Levitsky, J., O’Leary, J. G., Karvellas, C. J., Bajaj, J. S., Davenport, A., Jalan, R., Angeli, P., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.019 · Cited by 297
New Thrombopoietic Growth Factors
Kuter, D. J. (2009) · Clinical Lymphoma and Myeloma · doi:10.3816/clm.2009.s.034 · Cited by 285
The biology of thrombopoietin and thrombopoietin receptor agonists
Kuter, D. J. (2013) · International Journal of Hematology · doi:10.1007/s12185-013-1382-0 · Cited by 285
Preclinical Activity of Eltrombopag (SB-497115), an Oral, Nonpeptide Thrombopoietin Receptor Agonist
Erickson-Miller, C. L., Delorme, E., Tian, S.-S., Hopson, C. B., Landis, A. J., Valoret, E. I., Sellers, T. S., Rosen, J., Miller, S. G., Luengo, J. I., et al. (2009) · Stem Cells · doi:10.1634/stemcells.2008-0366 · Cited by 285
Self-citationLow‐grade endotoxemia and platelet activation in cirrhosis
Raparelli, V., Basili, S., Carnevale, R., Napoleone, L., Del Ben, M., Nocella, C., Bartimoccia, S., Lucidi, C., Talerico, G., Riggio, O., et al. (2017) · Hepatology · doi:10.1002/hep.28853 · Cited by 142
Metadata
- Authors
- McHutchison, J. G., Dusheiko, G., Shiffman, M. L., Rodriguez-Torres, M., Sigal, S., Bourliere, M., Berg, T., Gordon, S. C., Campbell, F. M., Theodore, D., Blackman, N., Jenkins, J., & Afdhal, N. H.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-11-29
- Volume
- 357
- Issue
- 22
- Pages
- 2227-2236
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2086647861
- Cited by
- 448
- References
- 10
- FWCI
- 30.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.